NCT00002450

Brief Summary

The purpose of this study is to see if giving tenofovir DF plus a combination of other anti-HIV drugs is safe and effective.

Trial Health

85
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P50-P75 for phase_3 hiv-infections

Geographic Reach
2 countries

61 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2000

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

August 31, 2001

Completed
Last Updated

June 24, 2005

Status Verified

July 1, 2000

First QC Date

January 17, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

HIV-1Drug Therapy, CombinationDrug Administration ScheduleRNA, ViralAnti-HIV AgentsViral Load

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients may be eligible for this study if they:
  • Are HIV-positive.
  • Have been on stable anti-HIV therapy for at least 8 weeks with no more than 4 anti-HIV drugs at the time of study entry.
  • Have a viral load (level of HIV in the blood) between 400 and 10,000 copies/ml.
  • Have good kidney function.
  • Are 18 to 65 years old.
  • Agree to use a barrier method of birth control (such as condoms) during the study and for 30 days after.

You may not qualify if:

  • Patients will not be eligible for this study if they:
  • Have a new AIDS-related illness diagnosed within 30 days of study entry.
  • Have any other serious medical conditions, including kidney or bone disease, an active infection requiring antibiotics, or cancer (other than Kaposi's sarcoma or certain skin cancers).
  • Have received a vaccine within 30 days of study entry.
  • Are unable to take medications by mouth.
  • Have ever taken tenofovir or adefovir dipivoxil.
  • Have taken certain medications within 30 days of study entry, such as chemotherapy, corticosteroids, medications that affect the kidneys, treatment for Kaposi's sarcoma, or certain experimental drugs.
  • Abuse alcohol or drugs.
  • Are pregnant or breast-feeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (61)

Univ of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Phoenix Body Positive

Phoenix, Arizona, 85016, United States

Location

Ocean View Internal Medicine

Long Beach, California, 90803, United States

Location

St Mary's Med Ctr

Long Beach, California, 90813, United States

Location

AIDS Healthcare Foundation-Research Center

Los Angeles, California, 90027, United States

Location

Kaiser Permanente LAMC

Los Angeles, California, 90027, United States

Location

LAC / USC Med Ctr / Infectious Diseases

Los Angeles, California, 90033, United States

Location

Cedars Sinai Med Ctr

Los Angeles, California, 90048, United States

Location

Tower Infectious Diseases / Med Associates Inc

Los Angeles, California, 90048, United States

Location

Robert Scott MD

Oakland, California, 94609, United States

Location

UCSD Med Ctr - Owen Clinic

San Diego, California, 921038681, United States

Location

Pacific Horizons Med Group

San Francisco, California, 94115, United States

Location

Kaiser Foundation Hospital

San Francisco, California, 94118, United States

Location

San Francisco VA Med Ctr

San Francisco, California, 94121, United States

Location

Harbor UCLA Med Ctr / Research and Educational Institute

Torrance, California, 90502, United States

Location

Univ of Colorado / Health Science Ctr

Denver, Colorado, 80262, United States

Location

Yale New Haven Hosp / Nathan Smith Clinic

New Haven, Connecticut, 06504, United States

Location

Yale-New Haven Hospital

New Haven, Connecticut, 06504, United States

Location

George Washington Univ Med Ctr

Washington D.C., District of Columbia, 20037, United States

Location

Physicans Home Service

Washington D.C., District of Columbia, 20037, United States

Location

Therafirst Med Ctr

Fort Lauderdale, Florida, 33308, United States

Location

ARTCTC

Ft. Pierce, Florida, 34950, United States

Location

Steinhart Medical Associates

Miami, Florida, 33133, United States

Location

Univ of Miami School of Medicine

Miami, Florida, 33136, United States

Location

Hillsborough County Health Dept

Tampa, Florida, 33602, United States

Location

Treasure Coast Infectious Disease Consultants

Vero Beach, Florida, 32960, United States

Location

AIDS Research Consortium of Atlanta Inc

Atlanta, Georgia, 30308, United States

Location

Ponce de Leon Med Ctr

Atlanta, Georgia, 30308, United States

Location

Northstar Med Clinic

Chicago, Illinois, 60657, United States

Location

Bendel Med Research

Lafayette, Louisiana, 70503, United States

Location

Dr Joel Gallant

Baltimore, Maryland, 21205, United States

Location

New England Med Ctr

Boston, Massachusetts, 02111, United States

Location

Massachusetts Gen Hosp

Boston, Massachusetts, 02114, United States

Location

Harper Hosp

Detroit, Michigan, 48201, United States

Location

Regions Hosp / HIV/AIDS Program

Saint Paul, Minnesota, 55101, United States

Location

Univ of NM

Albuquerque, New Mexico, 87131, United States

Location

Albany Med College

Albany, New York, 12208, United States

Location

Brookdale Univ Hosp and Med Ctr

Brooklyn, New York, 112123198, United States

Location

Howard Grossman

New York, New York, 10011, United States

Location

St Vincent's Hosp

New York, New York, 10011, United States

Location

Columbia Univ

New York, New York, 10032, United States

Location

Univ of Rochester Medical Center

Rochester, New York, 14642, United States

Location

Bronx Lebanon Hosp Ctr

The Bronx, New York, 10457, United States

Location

Nalle Clinic / Clinical Research Dept

Charlotte, North Carolina, 28207, United States

Location

Ian Baird

Columbus, Ohio, 43214, United States

Location

Remington Davis Inc

Columbus, Ohio, 43215, United States

Location

Oklahoma Univ Health Science Ctr

Oklahoma City, Oklahoma, 73104, United States

Location

Pennsylvania State College of Medicine

Hershey, Pennsylvania, 17033, United States

Location

Miriam Hosp / Brown Univ

Providence, Rhode Island, 02906, United States

Location

Dallas Veterans Administration Med Ctr

Dallas, Texas, 75216, United States

Location

Nicholas Bellos

Dallas, Texas, 75246, United States

Location

Thomas Street Clinic

Houston, Texas, 77009, United States

Location

Univ of Texas / Thomas Street Clinic

Houston, Texas, 77030, United States

Location

Univ TX San Antonio Health Science Ctr

San Antonio, Texas, 78284, United States

Location

Infectious Diseases Physicians Inc

Annandale, Virginia, 22003, United States

Location

Hampton Roads Med Specialists

Hampton, Virginia, 23666, United States

Location

Infections Ltd PS

Puyallup, Washington, 98371, United States

Location

Infections Ltd / Physicians Med Ctr

Tacoma, Washington, 98405, United States

Location

Ponce Univ Hosp

Ponce, 00731, Puerto Rico

Location

Clinical Research Puerto Rico Inc

San Juan, 009091711, Puerto Rico

Location

San Juan AIDS Program

Santurce, 00908, Puerto Rico

Location

MeSH Terms

Conditions

HIV Infections

Interventions

Tenofovir

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

OrganophosphonatesOrganophosphorus CompoundsOrganic ChemicalsAdeninePurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 3
Masking
DOUBLE
Purpose
TREATMENT
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 17, 2000

First Posted

August 31, 2001

Last Updated

June 24, 2005

Record last verified: 2000-07

Locations